ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19

NEXT STORY
NuGenerex Immuno-Oncology Announces Closing of a Licensing & Distribution Agreement with Bintai Kinden to Advance the Clinical Development & Commercialization of Ii-Key-SARS-CoV-2 Coronavirus Vaccine for Global Markets
PREV STORY
NEXLETOL® (bempedoic acid) Tablets Highlighted in EAS 2020 Presentation of Analysis Demonstrating Significant Cholesterol Lowering in People with Familial Hypercholesterolemia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Celon Pharma Hosting a Virtual Capital Markets Day on Wednesday, April 21st

author_avatar
NASDAQ Market News

BeyondSpring Reports First-Quarter 2020 Financial Results and Operational Update

author_avatar
NASDAQ Market News

Lilly Begins a Phase 3 Clinical Trial with Baricitinib for Hospitalized COVID-19 Patients

author_avatar
NASDAQ Market News